Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 03, 2026
AMCX: Can the Stock Deliver +38% to Reach $15?

AMCX: Can the Stock Deliver +38% to Reach $15?

Key Takeaways

  • Selected price target: $15 per share, representing roughly 38% upside from the recent trading range near $10.89 and a level the stock last traded above in early 2024.
  • Strongest bullish factors: Deeply discounted valuation with a trailing P/E (price-to-earnings) ratio in the low single digits, robust free cash flow generation exceeding $200 million annually, and a niche streaming portfolio that continues to grow revenue at double-digit rates.
  • Biggest risks: Persistent cord-cutting pressuring linear affiliate revenue, a consensus analyst rating of "Underperform" with average price targets below current levels, and approximately $1.3 billion in net debt weighing on the balance sheet.
  • Key technical levels: Support near $9.40 and resistance around $10.74; a sustained breakout above resistance would be necessary before any credible move toward $15 can begin.
  • Bottom line: While $15 is not an unrealistic long-term aspiration, it would require a significant positive shift in revenue trajectory, successful debt reduction, and a re-rating by Wall Street—conditions that are not yet in place.

The Significance of the $15 Level

The $15 price level carries both psychological and technical significance for AMCX. It sits roughly 38% above where shares recently traded near $10.89 and marks a zone the stock has not sustainably held since early 2024. For a company whose stock traded above $80 as recently as 2015—and above $30 in 2022—the idea of reclaiming $15 may not seem ambitious in historical context. Yet the media landscape has changed dramatically, and investors are now asking whether a return to even this modest threshold is achievable given the structural headwinds facing traditional cable networks.

Company Snapshot

AMC Networks Inc., which now operates under the name AMC Global Media Inc., is a New York-based entertainment company that develops, produces, and distributes content across television and streaming platforms. Its portfolio includes well-known cable networks such as AMC, IFC, SundanceTV, and WE tv, alongside a growing suite of direct-to-consumer streaming services including AMC+, Shudder, Acorn TV, ALLBLK, and Sundance Now. The company is behind major franchises including "The Walking Dead" and the Anne Rice Immortal Universe. Following an international divestiture in late 2023, domestic operations now account for roughly 90% of total revenue. With approximately 1,800 employees and annual revenue around $2.3 billion, AMC Networks remains a mid-sized player navigating the transition from linear television to streaming.

Valuation at a Glance

AMCX presents one of the more striking valuation profiles in the media sector. The stock trades at a trailing P/E ratio of roughly 4.5 and a forward P/E near 3.4, while its price-to-sales ratio sits at approximately 0.18. The company holds roughly $428 million in cash and generated free cash flow of $65 million in the first quarter of 2026 alone, with full-year guidance calling for at least $200 million. These metrics suggest a market that is pricing in substantial earnings erosion rather than stability or growth. The market capitalization of approximately $492 million stands in sharp contrast to annual revenue of about $2.25 billion, reflecting deep skepticism about the company's ability to maintain profitability as linear subscriber losses accelerate. From what I see, this level of discount stands out even in a challenged sector.

Bullish Drivers

Several factors could help AMCX build a case for reaching $15. First, the company's streaming segment has shown genuine momentum, with double-digit year-over-year revenue growth and a 44% increase in digital advertising revenue reported in the first quarter of 2026. Second, management has taken concrete steps to strengthen the balance sheet, retiring 2029 notes and extending roughly 75% of debt maturities into 2032, which reduces near-term refinancing risk. Third, the company's content library—anchored by enduring franchises—continues to generate licensing revenue and provides a foundation for monetization across multiple platforms. Fourth, a recently announced $30 million accelerated share repurchase program signals management's belief that shares are undervalued, and buybacks at current depressed levels could amplify per-share earnings over time. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Potential Roadblocks

The obstacles to reaching $15 are significant. Linear television affiliate revenue declined 16% in the most recent quarter, and that trend shows no sign of reversing as cord-cutting accelerates across the industry. Consolidated adjusted operating income (AOI) dropped 34% year-over-year in the first quarter of 2026, underscoring the profitability squeeze. The company carries approximately $1.3 billion in net debt and finance leases, representing net leverage of about 3.5 times. Meanwhile, competition for streaming subscribers has intensified, with far larger players such as NFLX and DIS commanding resources that AMC Networks cannot match. Finally, institutional ownership declined by over 9% in recent quarters, and the analyst community remains firmly cautious.

Analyst Consensus

Wall Street's current posture toward AMCX is notably cautious. Among the analysts actively covering the stock, the consensus rating is "Underperform" or "Reduce." Wells Fargo raised its price target to $10.00 in February 2026 while maintaining an Equal-Weight rating, making it one of the most optimistic voices on the Street. Morgan Stanley and J.P. Morgan both maintain Underweight ratings with price targets of $6.00 to $7.00. The average 12-month price target across all analysts sits between $7.00 and $8.50—well below the $15 threshold under discussion. Some aggregate forecasts point to a high estimate of $16.00, but these represent the most bullish outlier views rather than consensus expectations. For AMCX to reach $15, a substantial upward revision in analyst estimates would likely need to occur first.

Technical Analysis Perspective

From a technical analysis perspective, AMCX has established a trading range with identifiable boundaries. Support has repeatedly formed near the $9.40 level, with a deeper floor around $8.78 that has held through multiple tests in recent months. On the upside, resistance sits near $10.74, a level that has capped rallies and where the stock has repeatedly failed to sustain momentum. The 200-day moving average, around $8.50 to $9.25 depending on the data source, has recently been reclaimed, which is a modestly positive technical development. However, the stock remains in a longer-term downtrend that traces back to its 2015 all-time high of approximately $87. Any credible move toward $15 would require a decisive breakout above $10.74, followed by clearing the psychological $12.00 level—a zone that aligns with prior breakdown points from early 2024. One thing that stands out here is how the stock has respected these levels repeatedly.

Enhancing Research with AI Tools

In my own process, I often rely on Tickeron's AI Daily Buy/Sell Signals to add an objective layer when reviewing names like AMCX. The platform scans thousands of stocks and ETFs in real time, delivering Buy, Sell, or Hold signals grounded in technical patterns and market data. This helps cut through sentiment and focus on evolving conditions without needing to monitor every chart manually. It has become a practical complement to traditional fundamental work for me when weighing recovery scenarios.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: AMCX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AMCX in upward trend: price rose above 50-day moving average on July 31, 2026

AMCX moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend. In of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 31, 2026. You may want to consider a long position or call options on AMCX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMCX just turned positive on July 31, 2026. Looking at past instances where AMCX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMCX advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 180 cases where AMCX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AMCX moved out of overbought territory on August 17, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMCX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMCX broke above its upper Bollinger Band on August 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.561) is normal, around the industry mean (20.801). P/E Ratio (11.522) is within average values for comparable stocks, (112.428). Projected Growth (PEG Ratio) (0.545) is also within normal values, averaging (12.042). AMCX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (0.276) is also within normal values, averaging (2.960).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMCX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.

Notable companies

The most notable companies in this group are Netflix Inc. (NASDAQ:NFLX), Walt Disney Company (The) (NYSE:DIS), Roku (NASDAQ:ROKU), Paramount Skydance Corporation (NASDAQ:PSKY), AMC Entertainment Holdings (NYSE:AMC), iQIYI (NASDAQ:IQ), HUYA (NYSE:HUYA).

Industry description

Movies/entertainment industry include companies that produce and distribute motion pictures, and companies that operate general entertainment facilities like amusement parks and bowling centers. Some companies in this industry also have professional sports franchises. Live Nation Entertainment, Inc., Liberty Media Corp. and Viacom Inc. are some of the biggest companies in this space.

Market Cap

The average market capitalization across the Movies/Entertainment Industry is 18.01B. The market cap for tickers in the group ranges from 134 to 331.41B. NFLX holds the highest valuation in this group at 331.41B. The lowest valued company is LRDG at 134.

High and low price notable news

The average weekly price growth across all stocks in the Movies/Entertainment Industry was -1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 11%. NIPG experienced the highest price growth at 42%, while FTRK experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Movies/Entertainment Industry was -23%. For the same stocks of the Industry, the average monthly volume growth was -36% and the average quarterly volume growth was -51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 50
Price Growth Rating: 51
SMR Rating: 82
Profit Risk Rating: 74
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
AMCX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of cable television networks through its subsidiaries

Industry MoviesEntertainment

Profile
Details
Industry
Cable Or Satellite TV
Address
11 Penn Plaza
Phone
N/A
Employees
1738
Web
https://www.amcglobalmedia.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.